In breast cancer cells, Ras expression was reflected in high mitogen-activated protein kinase (MAP kinase) activity as well as EGFR (Epidermal Growth Factor Receptor) and erbB-2 overexpression [8,9,10]. Here, ERBB2 is linked to breast carcinoma.